No abstract available
Keywords:
ACC/AHA Practice Guideline; biomarkers, pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention.
MeSH terms
-
Adult
-
American Heart Association / organization & administration*
-
Cardiology / organization & administration*
-
Cholesterol, HDL / blood*
-
Cholesterol, LDL / blood*
-
Coronary Artery Disease / blood
-
Coronary Artery Disease / prevention & control*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hypercholesterolemia / blood
-
Hypercholesterolemia / drug therapy*
-
Risk Assessment
-
Risk Factors
-
Risk Reduction Behavior
-
Societies, Medical
-
Vereinigte Staaten
Substances
-
Cholesterol, HDL
-
Cholesterol, LDL
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors